Loading...

Combined BRAF(V600E) and MEK blockade for BRAF(V600E)-mutant gliomas

BRAF(V600E) is a common finding in glioma (about 10–60% depending on histopathologic subclassification). BRAF(V600E) monotherapy shows modest preclinical efficacy against BRAF(V600E) gliomas and also induces adverse secondary skin malignancies. Here, we examine the molecular mechanism of intrinsic r...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Neurooncol
Main Authors: Zhang, Jie, Yao, Tsun-Wen, Hashizume, Rintaro, Hariono, Sujatmi, Barkovich, Krister J., Fan, Qi-Wen, Prados, Michael, James, C. David, Weiss, William A., Nicolaides, Theodore
Format: Artigo
Sprog:Inglês
Udgivet: 2016
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5560871/
https://ncbi.nlm.nih.gov/pubmed/27848137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-016-2333-4
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!